ACC nixes satellite-symposia model

Share this article:
In a move aimed at better educating its members and reducing confusion between independent, CME-certified medical education and non-independent promotional events, the American College of Cardiology (ACC) is eliminating its traditional model for CME-certified satellite symposia at the Annual Scientific Session.
The new model will consist of CME-certified satellite symposia developed and certified by ACC, and offered through a new “in-depth” learning format within the Annual Scientific Session. Non-certified promotional events in different locations will also be permitted and will be overseen by the college's business development division.
The changes resulted from a three-year evaluation of educational satellite symposia headed up by chief learning officer Joseph Green, PhD. Until now, medical education companies, cardiovascular subspecialty societies and academic medical centers have been responsible for planning and developing satellite events, including managing grants processes.
“Our decision was the result of a thoughtful and comprehensive assessment of the ambiguous nature of traditional Satellite Symposia, which we feel puts us, and our Industry supporters, at greater regulatory risk and potentially confused our member learners,” noted Green and associate VP Elizabeth Yarboro in an email to MM&M explaining the changes, which will go into effect next year at the ACC.12 and i2 Summit.
Asked whether CME-certified satellite activities developed under the new format will continue to take support., they wrote, “we do not anticipate any changes to our criteria for independent grant support. We believe that industry support is perfectly acceptable—it's how these activities are designed, developed and implemented with that support that distinguishes truly independent medical education.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?